Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 November 1996 | Volume 125 Issue 10 | Pages 815-821
Background: Considerable debate is taking place over whether patients with basal-cell carcinoma and other skin neoplasms are at increased risk for internal cancer.
Objective: To investigate risk for subsequent cancer in patients with basal-cell carcinoma.
Design: Population-based cohort study.
Setting: Denmark, from 1978 to 1991.
Patients: 37 674 patients followed for a maximum of 14 years after a first diagnosis of basal-cell carcinoma.
Measurements: The occurrence of subsequent cancer was compared with the expected cancer pattern (which was determined on the basis of national incidence data). Standardized incidence ratios (SIRs), ratios of actual to expected number of cases of cancer, yielded estimates of the relative risk.
Results: During 190 945 patient-years of follow-up, 3663 new cases of cancer occurred where only 3245 were expected. As anticipated, malignant melanoma occurred frequently (SIR, 2.64 [95% CI, 2.21 to 3.13]), but patients were also at increased risk for noncutaneous cancer (SIR, 1.19 [CI, 1.13 to 1.24] for men and 1.09 [CI, 1.03 to 1.16] for women). The excess risk for noncutaneous cancer pertained to cancer of the lip (SIR, 2.07), salivary glands (SIR, 2.45), larynx (SIR, 1.41), lung (SIR, 1.40), breast (SIR, 1.13), and kidney (SIR, 1.30) and non-Hodgkin lymphoma (SIR, 1.36). Patients receiving a diagnosis of basal-cell carcinoma before 60 years of age (SIR, 1.26) had a statistically higher risk for developing new cancer (P < 0.01) than did those receiving the diagnosis at 60 years of age or older (SIR, 1.11). This applied to breast cancer (SIR, 1.37 in patients <60 years of age compared with 1.05 in those
Conclusion: In addition to having an increased risk for new skin cancer, patients with basal-cell carcinoma have an increased risk for noncutaneous cancer at various sites. Increased risks for testicular cancer, breast cancer, and non-Hodgkin lymphoma should be kept in mind, particularly for patients in whom basal-cell carcinoma is diagnosed when they are at a young age.
Author and Article Information
From Statens Seruminstitut and the Danish Cancer Society, Copenhagen, Denmark.
ARTICLE
Risk for Subsequent Cancer after Diagnosis of Basal-Cell Carcinoma: A Population-Based, Epidemiologic Study
60 years of age), testicular cancer (SIR, 3.52 in patients <60 years of age compared with 0 seen and 1.96 expected in those
60 years of age), and non-Hodgkin lymphoma (SIR, 2.50 in patients <60 years of age compared with 1.16 in those
60 years of age).
![]()
Acknowledgments: The authors thank Ms. Andrea Meersohn of the Danish Cancer Society for computer assistance.
Grant Support: By grant 94-100-17 from the Danish Cancer Society.
Requests for Reprints: Morten Frisch, MD, PhD, Danish Epidemiology Science Centre, Statens Seruminstitut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.
Current Author Addresses: Drs. Frisch, Hjalgrim, and Melbye: Danish Epidemiology Science Centre, Statens Seruminstitut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark.
Related articles in Annals:
This article has been cited by other articles:
![]() |
J. Chen, I. Ruczinski, T. J. Jorgensen, G. Yenokyan, Y. Yao, R. Alani, N. J. Liegeois, S. C. Hoffman, J. Hoffman-Bolton, P. T. Strickland, et al. Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy J Natl Cancer Inst, September 3, 2008; 100(17): 1215 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Theander, G Henriksson, O Ljungberg, T Mandl, R Manthorpe, and L T H Jacobsson Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors Ann Rheum Dis, June 1, 2006; 65(6): 796 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Nugent, A. A. Demers, M. C. Wiseman, C. Mihalcioiu, and E. V. Kliewer Risk of Second Primary Cancer and Death Following a Diagnosis of Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2584 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang, K. E. Smedby, H. Hjalgrim, A. Porwit-MacDonald, G. Roos, B. Glimelius, and H.-O. Adami Family History of Hematopoietic Malignancy and Risk of Lymphoma J Natl Cancer Inst, October 5, 2005; 97(19): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Smedby, H. Hjalgrim, M. Melbye, A. Torrang, K. Rostgaard, L. Munksgaard, J. Adami, M. Hansen, A. Porwit-MacDonald, B. A. Jensen, et al. Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas J Natl Cancer Inst, February 2, 2005; 97(3): 199 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, P. H. Owens, L. M. Morton, B. Zhang, K. Zou, S. Flynn, et al. Blood Transfusion and Risk of Non-Hodgkin's Lymphoma in Connecticut Women Am. J. Epidemiol., August 15, 2004; 160(4): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brewster, A. J. Alberg, P. T. Strickland, S. C. Hoffman, and K. Helzlsouer XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1271 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S M Wong, R C Strange, and J T Lear Basal cell carcinoma BMJ, October 4, 2003; 327(7418): 794 - 798. [Full Text] [PDF] |
||||
![]() |
B. A. Nexo, U. Vogel, A. Olsen, T. Ketelsen, Z. Bukowy, B. L. Thomsen, H. Wallin, K. Overvad, and A. Tjonneland A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55 Carcinogenesis, May 1, 2003; 24(5): 899 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MOLLER, H. WALLIN, E. HOLST, and L. E. KNUDSEN Sunlight-induced DNA damage in human mononuclear cells FASEB J, January 1, 2002; 16(1): 45 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Marcil and R. S. Stern Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer: A Critical Review of the Literature and Meta-analysis Arch Dermatol, December 1, 2000; 136(12): 1524 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Askling, P. Sorensen, A. Ekbom, M. Frisch, M. Melbye, B. Glimelius, and H. Hjalgrim Is History of Squamous-Cell Skin Cancer a Marker of Poor Prognosis in Patients with Cancer? Ann Intern Med, November 2, 1999; 131(9): 655 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonnerup Jaeger, A. Gramkow, H. Hjalgrim, M. Melbye, and M. Frisch Bowen Disease and Risk of Subsequent Malignant Neoplasms: A Population-Based Cohort Study of 1147 Patients Arch Dermatol, July 1, 1999; 135(7): 790 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DErrico, A. Calcagnile, I. Iavarone, F. Sera, G. Baliva, L. M. Chinni, R. Corona, P. Pasquini, and E. Dogliotti Factors That Influence the DNA Repair Capacity of Normal and Skin Cancer-affected Individuals Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 553 - 559. [Abstract] [Full Text] |
||||
![]() |
M. Frisch, H. Hjalgrim, F. Levi, L. Randimbison, and C. La Vecchia Re: Nonmelanomatous Skin Cancer Following Cervical, Vaginal, and Vulvar Neoplasms: Etiologic Association • RESPONSE J Natl Cancer Inst, March 17, 1999; 91(6): 565 - 566. [Full Text] [PDF] |
||||
![]() |
J. S. Spratt Jr, H. S. Kahn, and M. J. Thun Cancer Mortality After Nonmelanoma Skin Cancer JAMA, January 27, 1999; 281(4): 325 - 325. [Full Text] [PDF] |
||||
![]() |
P. Meier, I. Sterker, and T. Meier Primary Basal Cell Carcinoma of the Caruncle Arch Ophthalmol, October 1, 1998; 116(10): 1373 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kahn, L. M. Tatham, A. V. Patel, M. J. Thun, and C. W. Heath Jr Increased Cancer Mortality Following a History of Nonmelanoma Skin Cancer JAMA, September 9, 1998; 280(10): 910 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
Risk of Internal Cancer after Diagnosis of BCC Journal Watch Dermatology, March 1, 1997; 1997(301): 10 - 10. [Full Text] |
||||